Anti-Nephrin Antibodies in Minimal Change Disease
Approach to the Patient with Peritoneal Dialysis Catheter Dysfunction- Part 1
Want to write a case report? RFN has you covered with a list of journals to choose from
Have a Nephrology Question? There Might Be A #Tweetorial For That!
Conferences, Courses, & Grants
FOAMed
Interventional Nephrology Series
Focus on Point-of-Care Ultrasound in Nephrology (POCUN) Series
Kidney Biopsy of the Month Series
Episode 2 of the Renal Pathology Series
Check out the next installment of Renal Pathology Teaching Series from the Division of Nephrology at Washington University in St. Louis.
Top nephrology-related stories of 2015
What a year 2015 turned out to be. Nephrology social media is beginning to mature with many projects adding to a rich educational experience online. Who needs MOC when you have this! NephJC continues to be one of…
Stop-IgA: Immunosuppression for proteinuric IgA Nephropathy
Despite being the world’s most common form of glomerulonephritis, IgA Nephropathy treatment strategies have hereto been controversial, particularly surrounding the use of immnosuppression on top of traditional RAAS blockade. The long awaited, Intensive Supportive Care plus Immunosuppression in…
Donor smoking and recipient outcomes in kidney transplantation
I evaluated a young kidney donor candidate in clinic a few days ago and although he did not have any obvious medical issues and was an excellent candidate, he has been smoking half-a-pack a day of cigarettes for…
Lazarus Kidney
For my inaugural RFN post, a special case I saw last year with Dr. David Mount and Young-Soo Song a fellow nephrologist in training at BMC. A 74-year-old man with history of HTN, peripheral artery disease, CKD (baseline…
Renal Pathology Series from WashU
Check out the excellent renal clinico-pathology conference series from Tim Yau from the Washington University in St. Louis Division of Nephrology. Follow Tim on Twitter @Maximal_Change. This is a great addition to the kidney blogosphere.
Pharmacokinetic Alterations in the Elderly; You’re Not Too Young to Understand
Renal transplantation reduces mortality in elderly patients by more than 50%, however, challenges are magnified in elderly renal transplant recipients (RTR) when managing their pharmacotherapy regimen. Aging is associated with changes in several pharmacokinetics parameters including absorption, distribution, metabolism,…
Targeting Uric Acid in CKD
In our search for therapies to reduce CKD progression, hyperuricemia has historically not been a major target despite being a potential risk factor for progression. Two recent studies however, raise the possibility that treating hyperuricemia could slow progression….
Top Nephrology ’15 Contender: Treating Hepatitis C Infection in CKD: Results of the Surfer-C Study
Hepatitis C infection is a major public health issue, affecting approximately 2.8% of the world’s population (>185 million people worldwide). Approximately 250,000 Canadians were living with chronic hepatitis C as of 2011.Specifically in the hemodialysis population,DOPPS data estimated…
What does SPRINT mean for HTN and CKD?
There has been much fanfare regarding the release of the SPRINT trial in the last several weeks. Finally, evidence that intensive blood pressure reduction is good! But, does this apply to everyone? Is there adverse risk to lowing…